According to IMARC Group’s latest report, titled “Tissue Engineering Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.’the global tissue engineering market reached a value of US$ 13.84 Billion in 2021.Tissue engineering refers to a process of developing biological substitutes that aid in replacing, maintaining, restoring and improving damaged tissues and organs in the body. It involves combining cells, active molecules and scaffolds into functional tissues. Tissue engineering also acts as an effective alternative to surgical reconstructive procedures, mechanical devices and transplants. As a result, it finds extensive application in dentistry, orthopedics, neurology, cardiovascular, skin and musculoskeletal branches of medical sciences.
Request for a PDF sample of this report: https://www.imarcgroup.com/tissue-engineering-market/requestsample
The global tissue engineering market is primarily being driven by the increasing prevalence of obesity, cancer, diabetes and cardiovascular disorders among the masses. In line with this, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Moreover, various technological advancements, such as the launch of organ-on-a-chip solutions and three-dimensional (3D) bioprinters, are favoring the market growth. Other factors, including the implementation of favorable government policies for improving healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are creating a positive outlook for the market. Looking forward, IMARC Group expects the market to reach US$ 29.91 Billion by 2027, exhibiting at a CAGR of 13.10% during 2022-2027.
Checkout Now: https://www.imarcgroup.com/checkout?id=2073&method=1
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
Competitive Landscape:
- AbbVie Inc.
- Braun Melsungen AG
- Baxter International Inc
- Becton
- Dickinson and Company
- Integra LifeSciences Corporation
- Organogenesis Holdings Inc
- RTI Surgical
- Smith & Nephew plc
- Stryker Corporation
- Vericel Corporation
- Zimmer Biomet.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global tissue engineering market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.
Breakup by Type:
- Synthetic Scaffold Material
- Biologically Derived Scaffold Material
- Others
Breakup by Application:
- Orthopedics and Musculoskeletal
- Neurology
- Cardiovascular
- Skin and Integumentary
- Dental
- Others
Breakup by End User:
- Hospitals and Clinics
- Ambulatory Facilities
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/tissue-engineering-market
Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
0
